SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-18-000314
Filing Date
2018-11-06
Accepted
2018-11-06 16:14:52
Documents
25
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cncl1029form10q.htm 10-Q 166575
2 EXHIBIT 31.1 cncl1029form10qexh31_1.htm EX-31.1 8173
3 EXHIBIT 31.2 cncl1029form10qexh31_2.htm EX-31.2 8210
4 EXHIBIT 32.1 cncl1029form10qexh32_1.htm EX-32.1 4383
  Complete submission text file 0001554795-18-000314.txt   614544

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cncl-20180930.xml EX-101.INS 29400
6 XBRL SCHEMA FILE cncl-20180930.xsd EX-101.SCH 7307
7 XBRL CALCULATION FILE cncl-20180930_cal.xml EX-101.CAL 17091
8 XBRL DEFINITION FILE cncl-20180930_def.xml EX-101.DEF 5046
9 XBRL LABEL FILE cncl-20180930_lab.xml EX-101.LAB 65775
10 XBRL PRESENTATION FILE cncl-20180930_pre.xml EX-101.PRE 45863
Mailing Address 2157 S. LINCOLN SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN SALT LAKE CITY UT 84106 801-323-2395
CANCER CAPITAL CORP (Filer) CIK: 0001130889 (see all company filings)

IRS No.: 911803648 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-32363 | Film No.: 181163135
SIC: 6770 Blank Checks
Assistant Director All